Menin and Brain Aging: One Protein That Restores Memory in Mice

Every few months, a study is published that tells the same story in a new variation: we took old tissue, identified a single molecule that declined with age, restored it, and function returned. We've seen this with NAD in mitochondria, with Yamanaka factors in cells, and with certain proteins in blood. Now, a new study reported in May 2026 adds a surprising player to the list: a protein called Menin, whose decline in the brain drives the process of cognitive aging.

The story is particularly interesting because of the ending: the researchers not only identified the declining protein, they found a way to bypass the damage. Administration of a relatively simple and available amino acid, D-Serine, restored memory in old mice. This turns a dry mechanistic study into something with clinical potential, and that's exactly why it's worth understanding what was actually found, and what wasn't.

The connection between Menin and brain aging is an excellent example of a recurring principle in longevity research: sometimes behind a complex process like forgetfulness lies a single component that can be targeted. But as always, the distance between a lab mouse and a pill you swallow in the morning is enormous.

What is Menin?

Menin is a protein encoded by the MEN1 gene. It is primarily known to oncologists because mutations in this gene cause a rare endocrine tumor syndrome. But it turns out that in the brain, it has a completely different role. Here's what's important to know:

• It is a regulator of gene expression. Menin acts within the cell nucleus as part of protein complexes that control the activation and silencing of genes, including through epigenetic histone modifications.
• It controls inflammation. In the nervous system, Menin participates in restraining inflammatory pathways. When its levels are normal, it keeps the brain's immune cells, microglia, in a balanced state.
• Its levels decline with age. This is the key discovery: in the brains of old mice, the amount of Menin in neurons is significantly lower compared to young mice.
• It affects neural signaling. The decline in Menin doesn't stay in the nucleus. It translates into changes in how neurons communicate with each other, especially in areas responsible for memory.

In other words, Menin is not just a random protein. It is a hub connecting three processes we all know accelerate brain aging: gene regulation, inflammation, and synaptic signaling.

The Connection to Menin and Brain Aging: A Triple Mechanism

How exactly does a decline in one protein translate into forgetfulness? The study points to a chain of events with three stages that feed into each other:

1. Loss of the inflammatory brake. When Menin levels drop, the restraint on microglia weakens. These cells, which are supposed to protect the brain, shift into a persistent pro-inflammatory state and secrete cytokines like TNF-alpha and IL-6. The result is chronic neuroinflammation, one of the main drivers of brain aging, which erodes synapses and nerve cells themselves.

2. Disruption of neuronal signaling. Inflammation and changes in gene expression impair the ability of neurons to transmit signals to each other efficiently. The focus here is synaptic plasticity: the ability of neural connections to strengthen or weaken in response to experience, which is the biological basis of learning and memory. When plasticity is impaired, the brain struggles to form and retain new memories.

3. D-Serine deficiency. Here comes the clever connection of the study. The researchers found that the decline in Menin is linked to a decrease in D-Serine levels in the brain. D-Serine is an amino acid that serves as a co-agonist of NMDA receptors, a type of glutamate receptor critical for synaptic plasticity. Without enough D-Serine, NMDA receptors don't open properly, and the neural signal responsible for memory strengthening weakens.

This chain explains why it was possible to bypass the damage: even without restoring Menin itself, replenishing D-Serine acted directly on NMDA receptors and restored the lost synaptic signal. It's like fixing the final outcome of a malfunction instead of fixing the original problem.

Current Evidence

Study 1: Decline of Menin in Old Mice

In the first stage, the researchers compared Menin levels in the brains of young mice versus old mice. It was found that the concentration of Menin in neurons of the hippocampus, a key memory region, declined significantly with age. To prove causality, they silenced the MEN1 gene in healthy young mice and observed that the mice developed symptoms of premature brain aging, including increased neuroinflammation and poor memory performance.

Study 2: Behavioral Memory Tests

Memory was measured using standard behavioral tests in mice, such as the Morris water maze and novel object recognition. Old mice, and young mice in which Menin was silenced, showed a significant decline in the ability to learn and remember locations and objects. They struggled to remember where an escape platform they had previously found was located, a classic sign of impaired hippocampus-dependent memory.

Study 3: Memory Restoration with D-Serine

This is the central finding. When old mice received D-Serine supplementation, their performance on memory tests improved and approached that of young mice. At the cellular level, the researchers observed restoration of synaptic plasticity in the hippocampus. In other words, not only did behavior improve, but the cellular mechanism underlying memory was repaired.

Study 4: The Broader Context of NMDA Modulation

The finding fits into existing knowledge about NMDA receptors and aging. Previous studies have shown that a decline in NMDA receptor function is a hallmark of the aging brain, and that systems supplying D-Serine weaken with age. The new study adds the missing link: it explains why D-Serine levels decline in the first place, connecting it to a single regulatory protein.

What About Alzheimer's and Neurodegenerative Diseases?

The connection between neuroinflammation, NMDA receptors, and memory is not unique to normal aging. It is central to several neurodegenerative diseases. In Alzheimer's, for example, there is evidence of dysfunction in the glutamate-NMDA system, and the drug memantine acts precisely on this pathway (though as a partial antagonist, to prevent overstimulation).

If Menin decline indeed contributes to inflammation and D-Serine deficiency, there may be a common pathway relevant not only to healthy aging but also to memory diseases. This doesn't mean D-Serine is a cure for Alzheimer's, far from it, but it places the finding in a broader context that interests many researchers.

It's important to note: modulation of NMDA receptors is a double-edged sword. Overstimulation of them causes excitotoxicity, a process where neurons are killed by excessive stimulation. This is why in Alzheimer's, a blocker is used, not an enhancer. Hence, any approach attempting to boost NMDA activity must navigate very carefully between memory improvement and the risk of damage.

Should We Start Taking D-Serine?

D-Serine is sold as a dietary supplement and is available. So why not just start? Several weighty reasons:

• The study was done in mice, not humans. This is a caveat that cannot be bypassed. Hundreds of interventions have restored memory in mice and failed in humans. A mouse is not a perfect model for the human brain, certainly not for its aging over decades.
• The doses and context are completely different. The dose given to a lab mouse, relative to its body weight and under controlled conditions, does not simply translate to a human pill. An incorrect dose of a substance acting on NMDA receptors can be harmful.
• NMDA modulation carries real risks. As noted, overstimulation of NMDA receptors is linked to excitotoxicity and neural damage. The line between a beneficial and harmful dose may be narrow, and it is unknown in a healthy human.
• There are no long-term safety data. Taking an amino acid that alters central neural signaling for years is something no one has tested. Possible side effects, interactions with medications, and effects on mood and anxiety are all unknown in this context.
• D-Serine has already been studied in schizophrenia, where it was tested as an add-on treatment, with mixed results. This shows there is research interest, but also that the path to approval and safe use is long.

The bottom line: This is an exciting mechanistic finding, not a clinical recommendation. Anyone who rushes to buy D-Serine based on a headline about mice is getting ahead of the science by years and may be taking an unnecessary risk.

What Can We Take from the Study?

1. Do not start D-Serine supplementation on your own. Current evidence does not justify this in healthy humans, and the risks of NMDA modulation are real. If you are still interested, this is a conversation for a doctor, not an independent decision.
2. Focus on reducing neuroinflammation through proven methods. One axis of the study is that Menin decline drives inflammation. Chronic neuroinflammation is heavily influenced by lifestyle: an anti-inflammatory diet, regular physical activity, and quality sleep all reduce it, without risk.
3. Keep your NMDA receptors healthy naturally. Aerobic exercise increases BDNF levels and strengthens synaptic plasticity, the same mechanism the study attempts to restore. This is the safest and most proven intervention for the aging brain.
4. Follow the research, not the headline. If you want to know if there's something real here, look in a year or two for studies beginning in humans. Until then, it's a promise, not a product.
5. Feed your brain quality protein. Amino acids, including precursors to D-Serine, come from a balanced diet. No dedicated supplement is needed to provide the brain with the building blocks it needs.

The Broader Perspective

The story of Menin and brain aging joins a larger pattern emerging in the last decade: aging is not one opaque block, but a collection of specific deficits, each of which may be repairable. When the right declining molecule is identified, sometimes a seemingly lost function can be restored.

But the same story also teaches the opposite lesson. Restoring a single molecule in a lab does not equal treating humans. The path from a mouse with restored memory to a human enjoying the same effect goes through safety, dosing, and side-effect studies that take years. In the meantime, the tools truly proven on the human brain—exercise, sleep, diet, and inflammation control—act on exactly the same pathways this study points to.

The message to remember: Behind every deficit of aging lies a mechanism, and behind every mechanism lies an opportunity, but also a temptation to get ahead of the science. Curiosity about Menin and D-Serine is entirely justified. The rush to the pharmacy, less so.

References:
Tech Times - Brain Aging Reversal in Mice: Menin Protein Loss and D-Serine
PubMed - Menin, NMDA Receptors and Synaptic Plasticity